All Notebooks | Help | Support | About
21st May 2014 @ 01:56

Thirteen Series 4 compounds have been submitted for biological evauation against plasmodium falciparum and TB (awaiting details of TB assay). The compounds are a mixture of ether, thioether, amine and amide linked compounds, along with two key building blocks.

Single Shot Potencies were obtained: Single Shot Potencies for Compounds Submitted to GSK

 

Additionally, some Series 3 compounds were sent for testing.

Some compounds inherited from at TB project also being performed in the Todd Lab were also sent for evaluation.

Data to be posted later.

Originally authored by Alice

Linked Posts
Attached Files
Series 3 Compounds.cdxml
Series 4 Compounds.cdxml
TB Inherited Compounds.cdxml
Series 3 Compounds.png
Series 4 Compounds.png
TB Inherited Compounds.png